The product of Snail gene is a repressor of E-cadherin transcription and an inductor of the epithelial-to-mesenchymal transition in several epithelial tumor cell lines. In order to examine Snail expression in animal and human tissues, we have raised a monoclonal antibody (MAb) that reacts with the regulatory domain of this protein. Analysis of murine embryos shows that Snail is expressed in extraembryonic tissues and embryonic mesoderm, in mesenchymal cells of lungs and dermis as well as in cartilage. Little reactivity was detected in adult tissues as Snail was not constitutively expressed in most mesenchymal cells. However, Snail expression was observed in activated fibroblasts involved in wound healing in mice skin. Moreover, Snail was detected in pathological conditions causing hyperstimulation of fibroblasts, such as fibromatosis. Analysis of Snail expression in tumors revealed that it was highly expressed in sarcomas and fibrosarcomas. In epithelial tumors, it presented a more limited distribution, restricted to stromal cells placed in the vicinity of the tumor and to tumoral cells in the same areas. These results demonstrate that Snail is present in activated mesenchymal cells, indicate its relevance in the communication between tumor and stroma and suggest that it can promote the conversion of carcinoma cells to stromal cells.
Introduction
The Snail family members Snail (Sna1) and Slug (Sna2) are essential for triggering epithelial-to-mesenchymal transitions (EMTs) during embryonic development and tumor progression (Nieto, 2002; Barrallo-Gimeno and Nieto, 2005; De Craene et al., 2005; Huber et al., 2005) . The products of both genes are transcriptional repressors that are able to bind and inhibit E-cadherin promoter activity (Batlle et al., 2000; Cano et al., 2000) . Snail-induced E-cadherin depletion is necessary for early phases of embryonic development, as mice deficient in Sna1 expression fail to downregulate Ecadherin levels and to complete gastrulation (Carver et al., 2001) . Repression of E-cadherin transcription is also particularly relevant during the late steps of epithelial tumorigenesis, as a causal relationship between loss of expression of this protein and the invasive properties of some tumors has been established (Vleminckx et al., 1991; Perl et al., 1998) . Besides Sna1 and Sna2, other transcriptional factors (Zeb1/dEF-1, Zeb2/ SIP1 and E12/E47) have been shown to bind to E-cadherin promoter and repress its activity (Grooteclaes and Frisch, 2000; Comijn et al., 2001; Pe´rez-Moreno et al., 2001) .
Sna1 expression in adult tissues has been performed by analysing its corresponding RNA. However, as the subcellular localization and stability of this transcriptional factor are sensitive to Ser/Thr phosphorylation (Domı´nguez et al., 2003; Zhou et al., 2004; Yang et al., 2005; Yook et al., 2005) and Lys oxidation (Peinado et al., 2005) , Snail mRNA and protein levels do not necessarily correlate. We present in this work the results obtained with a mouse monoclonal antibody (MAb) developed in our laboratories that enables the detection of this protein in embryos and in normal and pathological adult tissues.
Results
Analysis of hybridoma supernatants by enzyme-linked immunosorbent assay (ELISA) indicated that MAb EC3 showed the highest affinity for Snail protein and presented a similar titer for the human and murine forms of Snail (Figure 1a) . Mapping of the epitope indicated that it reacts with the 1-82-amino acid sequence of the protein (Figure 1a) . The MAb did not crossreact with Sna2 (Slug), as demonstrated by the lack of signal in RWP-1 cells transfected with a GFP-Sna2 fusion protein (Figure 1c) .
In Western blot analysis, MAb EC3 recognized a band of 32 kDa present in epithelial cells only when Snail was overexpressed (Figure 1b) . The immunoreactivity was more intense in cells incubated with the proteasome inhibitor MG132, which has been reported to stabilize Snail protein (Zhou et al., 2004) . Monoclonal antibody EC3 reacted also with a protein of similar molecular mass in NIH3T3 murine fibroblasts and to a less extent in SW-620 human colon carcinoma cells. In both cases, the amount of detected protein was sensitive to addition of MG132. By immunofluorescence, the reactivity was mainly observed in the nuclei of cells stably transfected with Sna1 ( Figure 1c ). Endogenous Snail was also observed in NIH3T3 cells and human primary fibroblasts, with a characteristic nuclear pattern excluding nucleoli, and also in SW-620 cells, although in the latter cells reactivity was highly dependent on addition of the proteasome inhibitor ( Figure 1c ).
We used MAb EC3 to analyse Snail protein expression during different steps of embryonic development. Similar to results previously described for Sna1 mRNA (Nieto et al., 1992) , immunoreactivity for Snail protein was detected in extraembryonic tissues at early stages of development (Figure 2a) . At day E7.5 embryos, Snail expression was restricted to mesoderm (Figure 2a) . Parietal endoderm cells also showed a strong immunoreactivity. At day E9.5, Snail reactivity was detected in branchial arches (Figure 2d ), another area with a wellcharacterized expression of Sna1 transcript (Nieto et al., 1992) . At day E15, immunoreactivity was particularly high in cartilage, probably reflecting the elevated expression of Sna1 in chondrocytes (Figure 2e ). Snail protein was also detected in mesenchymal cells, as shown in Figure 2f for the lungs. Levels of Snail protein were significantly lower in these cells after birth ( Figure 2g) .
Recently, Snail has been shown to play a role in the cutaneous hair follicle morphogenesis (Jamora et al., 2005) . Using our MAb, immunoreactivity for Snail was detected in dermal mesenchymal cells adjacent to the hair bud (dermal condensate) but not in the epithelial cells (Figure 2h ). After birth, Snail expression was limited to the mesenchymal cells in the dermal papilla ( Figure 2i ). These results show that MAb EC3 detects We also analysed whether such a restricted expression of Snail in mesenchymal cells was associated to a regulated expression of this protein in fibroblasts. First, we analysed Snail protein levels in murine NIH3T3 and primary human fibroblasts under different conditions. As shown in Figure 3 , expression of Snail was not constitutive but dependent on serum in both cellular systems. Serum starvation of NIH3T3 cells completely downregulated immunoreactivity for Snail protein.
Snail levels were stimulated after re-addition of serum. A kinetic study indicates that maximal amounts of protein were reached after 3 h and decreased later on, although to levels much higher to those detected in serum-depleted cells (Figure 3b ). Sna1 RNA levels were also sensitive to serum, suggesting that regulation takes place at the transcriptional level (Figure 3c ).
The expression of Snail only in activated fibroblasts was also verified using a wound healing assay in mice. In animals, healing of the skin is a wellknown process that requires recruitment of primed fibroblasts to the wound (Martin, 1997) . As observed in Figure 4 , these fibroblasts were positive for Snail expression especially during the proliferative phase (days 3 and 5). Reactivity was much lower at later stages, when re-epithelization of the wound has progressed (day 7).
We also analysed Snail expression in pathological conditions in which fibroblasts are stimulated. Fibromatoses are benign lesions characterized by the proliferation of elongated fibroblast-like cells that infiltrate the surrounding soft tissues. As shown in Figure 5a and b, a remarkable proportion of these cells was positive for Snail expression. As expected, reactivity was restricted to the nuclei. 
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The presence of Snail was studied in fibrosarcomas and sarcomas, two types of tumors derived from mesenchymal cells: as shown in Figure 5c -e, the reactivity was detected in the nuclei of a high percentage of the cells, either with a fibroblastic morphology (mainly in fibrosarcomas, Figure 5c Activation of stromal fibroblasts has also been observed in carcinomas (Liotta and Kohn, 2001; Stuelten et al., 2005) . Therefore, we analysed a small set of human tumors for Snail reactivity (in tumor cells and adjacent stroma). As shown in Figure 6a -f, few cells from a cervical squamous cell carcinoma presented immunoreactivity for Snail protein. Reactive cells were detected in the stroma, normally as groups of Snailpositive cells, and always close to the carcinoma cells (see Figure 6c and d) . Occasionally, cells expressing Snail were also localized among carcinoma cells (Figure 6b ). These cells were always present at the edge of the tumor cell islands, and normally close to stromal cells positive for Snail.
Similar results were observed in colon carcinomas (Figure 6g-p) . In most of the cases, the percentage of Snail-positive cells was low and Snail protein was mostly detected in stromal cells close to the tumor cell islands. In some occasions, these stromal cells presented classic features of fibroblasts (Figure 6g-i) , whereas in other they looked more like undifferentiated mesenchymal cells ( Figure 6o ). As described above, some tumor cells also presented nuclear immunoreactivity for Snail (Figure 6l , n and p); these cells presented an epithelial phenotype and were also situated at the edges of the tumor cell islands. In some cases, as the cell showing expression of Snail in Figure 6k , it seemed to be moving out from the tumor tissue.
We also performed a parallel analysis for Snail and E-cadherin in a small subset of carcinomas ( Figure 7 ). As expected, cells positive for Snail normally did not express E-cadherin (Figure 7a-d) . Presence of Snail was usually detected in cells located at the periphery of the tumor and adjacent to the stroma. In some cases, these Snail-positive cells still retained E-cadherin reactivity (see Figure 7e and f; to a higher extent, see Snail expression in human tumors C Francí et al Figure 7g and h). However, this pattern was very minor. Occasionally, single cells positive for Snail were detected inside the tumor cell mass (Figure 7j and l). These cells were not stained with E-cadherin antibody and presented an elongated and flat morphology.
Discussion
The expression of Snail transcriptional factor has been detected in tumor cell lines during the process of EMT. Moreover, ectopic expression of this repressor promotes an EMT and inhibits transcription of E-cadherin and other markers specific of epithelia. However, the exact contribution of Snail to the repression of epithelial genes or to EMT 'in vivo' has not been studied owing to the lack of antibodies capable of detecting this protein in paraffin sections. Expression of Snail mRNA has been detected in biopsies from patients with breast (Blanco et al., 2002; Fujita et al., 2003; Elloul et al., 2005; Moody et al. 2005) , ovarian (Elloul et al., 2005) , gastric (Rosivatz et al., 2002) , colon (Palmer et al., 2004; Pen˜a et al., 2005) and hepatocellular carcinomas (Sugimachi et al., 2003) . Nevertheless, these studies are biased by the fact that Snail activity is influenced by covalent modifications of the protein: Ser/Thr phosphorylation or Lys oxidation of Snail modulates its subcellular location, stability and, therefore, the transcriptional effects of this factor (Domı´nguez et al., 2003; Zhou et al., 2004; Peinado et al., 2005; Yang et al., 2005; Yook et al., 2005) . Moreover, in some of the above-mentioned studies, the precise contribution of stromal and carcinoma cells to the expression of Sna1 was not assessed. May be owing to these reasons, other groups have been unable to detect Snail in some of these tumors (Rosivatz et al., 2004) .
In this work, we show the results of the immunohistochemical analysis of Snail in adult and embryonic tissues carried out with a novel MAb raised in our laboratories. This MAb recognizes an epitope located in the first 82 amino acids, a sequence that is substantially different from that of Slug (Sna2), a close member of the same family. Consequently, our MAb did not crossreact Figure 4 Activated fibroblasts express Snail during mice skin wound repair. Skin wounds of 2 mm diameter were made aseptically on CD-1 mice as indicated in Materials and methods. Wound tissue and surrounding skin from the wound margin skin were harvested from mice at 2, 3, 5 and 7 days post-wounding and fixed in formalin before paraffin embedding and sectioning. Paraffin sections (4 mm) were stained with hematoxylin and eosin (left panels) and analysed with monoclonal antibody EC3 as mentioned (center panels). Higher magnification ( Â 600) views of the indicated areas of the center panels are shown in the right column. A, adipose tissue; C, clot; E, epithelium; GT, granulation tissue (immature, at day 5; mature at day 7); N, inflammatory neutrophils and macrophages.
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C Francí et al with Slug. Our results indicated that Snail protein expression is detectable, although weakly, in tumor cell lines showing mesenchymal characteristics. The immunoreactivity was increased by addition of the proteasome inhibitor MG132, further supporting previous observations indicating that the Snail protein is unstable in most cell lines (Zhou et al., 2004) . As our MAb allowed the detection of Snail in paraffin-embedded specimens, we analysed the expression of this protein during mouse embryonic development. Our analysis showed a good correlation between the expression of this protein and the previously published results on the levels of Sna1 RNA (Nieto et al., 1992) . Snail protein was detected in the nuclei of cells positive for Sna1 RNA. Presence of Snail was much more abundant in embryonic than in adult tissues; for instance, Snail was easily detected in lung mesenchyma in the fetuses, but was barely detected after birth. Also the dermis presented a much more abundant immunoreactivity for Snail at E15 than in adults, where it was restricted to the nuclei of cells in the hair dermal papilla.
Recently, Snail has been shown to contribute to hair morphogenesis (Jamora et al., 2005) . Transient expression of Snail by epithelial cells in the dermal condensate is required for the generation of the hair germ. We did not detect immunoreactivity for Snail in cells with epithelial features, but in mesenchymal cells adjacent to the hair bud. It is possible that these Snail-positive cells correspond to cells that have already undergone an EMT and have an epithelial origin, as it has been proposed (Jamora et al., 2005) . Interestingly, a specific Snail immunoreactivity was also observed in the dermal papilla, the location of mesenchymal cells essential for hair growth (Jahoda et al., 1984) . 
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Our results indicate that Snail presents a limited distribution in a subset of mesenchymal cells and that its expression is not constitutive. In vivo and in vitro experiments demonstrated that Snail expression can be induced in fibroblasts; for instance, in human primary fibroblasts as well as in NIH3T3, Snail expression was greatly dependent on serum: serum deprivation of NIH3T3 cells downregulated Snail protein to undetectable levels. Addition of serum rapidly stimulated Snail protein and mRNA. These results agree with our previous observations indicating that Sna1 promoter activity and RNA levels are greatly dependent on the activity of ERK pathway (Barbera`et al., 2004) , a signaling pathway activated by addition of serum (data not shown). Moreover, using an in vivo wound-healing assay in mice, we found immunoreactivity for Snail only in actively migrating fibroblasts. When healing had progressed, and re-epithelization was complete, Snail immunoreactivity in fibroblasts fell down to the initial undetectable levels.
We also analysed the expression of Snail in pathological conditions in which activation of fibroblasts has been observed. Fibromatosis is a lesion characterized by the proliferation of fibroblast-like cells and presents a high potential for local invasiveness. These fibroblastlike cells are positive for Snail expression, which suggests that they correspond to activated fibroblasts, probably retaining the capability of migration. Other Figure 6 Snail is expressed in the tumor-stromal interface in squamous cervix or colon carcinomas. Samples corresponding to squamous cervix carcinomas (a-f) or colon carcinomas (g-p) were analysed with monoclonal antibody EC3 as described. Panels b and c show details from tumor presented in panel a; panel f corresponds to a higher magnification of view from panel e. Similarly, panel h corresponds to panel g, panels k and l, to j; and panels n and o, to p. The initial magnifications were as follows: (a, e, g, j, m and p) Â 75; (b-d, f and i) Â 300; (h, k, l, n and o) Â 600.
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C Francí et al tumors characterized by the proliferation of fibroblasts or other mesenchymal cells, such as fibrosarcomas and sarcomas, also presented a high expression of Snail. Activation of stromal fibroblasts has also been observed in carcinomas. It has been reported to depend on the production of tumor necrosis factor (TNF)-a and transforming growth factor (TGF)-b by tumor cells, and on the activation of Ras and phosphatidyl inositol 3-kinase (PI3-kinase) signaling in fibroblasts (Stuelten et al., 2005) . These two pathways are involved in Snail transcription in tumor cells (Peinado et al., 2003) . Expression of Snail is not general in the stroma, but in cells situated in the vicinity of the tumor, probably reflecting the activation of these cells. Moreover, tumor cells close to Snail-positive stroma were also positive, suggesting that tumor stroma was cooperating in tumor progression, something that has previously been shown in several experimental models (Olumi et al., 1999; Orimo et al., 2005) .
An alternative explanation might be formulated, suggesting that all Snail-positive cells in the stroma would arise from the epithelium, and Snail expression would happen concomitantly, and be necessary for the acquisition of this stromal phenotype. This explanation agrees with the hypothesis that activated fibroblasts originate from an EMT (Kalluri and Neilson, 2003) , although it would require that the activation of Snail expression was transient, and additional factors were responsible for the sustained repression of E-cadherin and other epithelial genes in fibroblasts and mesenchymal cells. In this respect, it has been shown that expression of E-cadherin repressor Zeb1 is induced by Snail and it can be maintained for at least 3 weeks after Snail has been eliminated (Guaita et al., 2002) . Therefore, Snail would be a very early marker of EMT and present only in stromal cells that have just gone through an EMT. Accordingly, we have not detected extensive co-staining of Snail and other markers of activated fibroblasts, such as S100A4 or SMA (data not shown); although we consider likely that Snail is probably necessary for triggering the expression of these genes, it would not be necessary for its maintenance.
This hypothesis is supported by the detection of tumor cells showing Snail expression. Normally, these cells are situated at the edge of the tumor mass, and they present an undifferentiated phenotype. However, occasionally, these tumor cells still retain an epithelial phenotype. Analysis of the epithelial master gene Ecadherin, a transcriptional target of Snail, confirmed these results. Although most of the Snail-positive cells Figure 7 Snail and E-cadherin expression in epithelial carcinomas. Consecutive sections were obtained from a larynx squamous carcinoma (a and b), and colon carcinomas (c-l) and analysed with anti-E-cadherin monoclonal antibody (a, c, e, g, i and k) or antiSnail MAb EC3 (b, d, f, h, j and l). The initial magnification of the micrographs was Â 300.
Snail expression in human tumors C Francí et al are negative for E-cadherin, we detected coexpression of both markers in a small proportion of cells. According to our model, they should correspond to cells at the initial stages of the EMT, where E-cadherin gene transcription has already been switched off but the protein still remains. In any case, it would be very interesting to characterize the determinants that are inducing expression of Snail in these tumors cells, and the precise contribution of the adjacent stroma. In this respect, as mentioned above, several reports have demonstrated a role for the stroma in the progression of carcinomas (Moinfar et al., 2000; Shekhar et al., 2001; Orimo et al., 2005) .
The possibility that Snail is triggering EMT in carcinomas has several implications. First, the detection of Snail in tumor cells should be the initial marker of EMT and predict those cells that are going to detach from the tumor. Second, this transition might be more general than what has previously been considered and might be taking place in a high number of carcinomas, although to a limited extent. It is possible that the single cells positive for Snail in tumors might correspond to cells that are going through this transition. And third, a substantial number of stromal cells might have been originated from the tumor. In this respect, several reports have provided evidence indicating that stromal cells might arise from carcinoma cells (Petersen et al., 2003; Galie et al., 2005) .
In summary, our results provide new evidences of a role for Snail transcriptional factor in human tumors and open new perspectives for the study of the role of this protein in the process of tumor invasion and its relationship to fibroblast activation.
When this manuscript was under revision, an article by Rosivatz et al. (2006) was electronically published. In this work, the authors describe the characterization of a MAb that reacts with human Snail in paraffin sections. The limited expression of Snail detected in tumors of the upper gastrointestinal tract agrees with our results indicating that Snail protein is probably not responsible for the maintenance of the invasive phenotype of epithelial tumors.
Materials and methods

Production of Snail monoclonal antibodies
Monoclonal antibodies were raised against GST-murine-Sna1 fusion protein according to standard techniques. Immunization was started with 9-week-old Balb-C mice (Harlan, Horst, The Netherlands) by injecting 1-2 mg of antigen subcutaneously by using ImmunEasy adjuvant (Qiagen, Hilden, Germany) and repeated two more times. Three days before fusion, the mice received a fourth immunization in the tail vein using antigen in phosphate-buffered saline (PBS). X63-Ag8.653 myeloma cells were used for fusion. Hybridomas were selected by enzyme-linked immunosorbent assay with Snail fusion protein and Snail-transfected human gingival squamous cell carcinoma cells as targets for immunostaining. The hybridomas were cloned by picking single cells from the cultures and were cultured in RPMI 1640 medium supplemented with 10 or 20% fetal calf serum and antibiotics.
Two hybridomas, 173EC3 and 173CE2, were established with identical properties and subcloned. The study plan for production of the antibodies was approved by the Animal Experimentation Committee of University of Helsinki (Helsinki, Finland).
Analysis of Snail protein expression by Western blot and immunofluorescence NIH-3T3 murine fibroblasts, human primary fibroblasts or the colon carcinoma cell lines SW-620 or HT-29 M6 expressing Snail-HA cDNA (Batlle et al., 2000) were grown in standard conditions in the presence of 10% fetal bovine serum (FBS). When indicated, the proteasome inhibitor MG132 (10 mM, Sigma, St Louis, MO, USA) was added for 2 h. Serum starvation was achieved by culturing the cells in 0.01% FBS for 24 h. Protein cell extracts were prepared by incubating cell pellet with RIPA buffer (50 mM Tris-HCl, pH 8, 150 mM NaCl, 1 mM ethyleneglycol tetraacetate, 1% sodium deoxycholate; 1% Triton X-100, 0.2% sodium do-decyl sulphate (SDS) plus protease and phosphatase inhibitors (5 mM NaF, 1 mM sodium ortovanadate, 2 mM beta-glycerolphosphate, 10 mg/ml leupeptin, 2 mM Pefablock, 10 mg/ml aprotinin, 10 mg/ml pepstatin) on ice for 30 min. Cell lysates were then centrifuged at 13 200 r.p.m. for 15 min and 60 mg of the supernatant was used for Western blot analysis. Samples were separated by 15% polyacrylamide gel electrophoresis under reducing conditions in the presence of SDS (SDS-PAGE). After transfer on nitrocellulose sheets, membranes were analysed with MAb 173EC2 (1:40 dilution of hybridoma supernatant; overnight at 41C). Immunofluorescence was performed as described previously (Domı´nguez et al., 2003) . Cells were incubated with undiluted hybridoma supernatant overnight at 41C. After washing three times with PBS, binding of primary antibody was detected by anti-mouse Alexa 488 (Molecular Probes, Carlsbad, CA, USA), diluted 1/500 in PBS/1% BSA/0.1% saponin. Controls with an irrelevant MAb or in absence of primary antibody confirmed the specificity of the immunolabelling. The specimens were studied with a TCS-SP2 Leica confocal microscope or Olympus Provis digital microscope.
Quantitative reverse transcription-PCR analysis
Total RNA was extracted using the Gen Elute Mammalian total RNA kit (Sigma). Quantitative determination of Snail RNA levels was performed in triplicate using QuantiTect SYBR Green RT-PCR (Qiagen) and oligonucleotides 5 0 -TT CCAGCAGCCCTACGACCAG-3 0 (forward) and 5 0 -CTTTC CCACTGTCCTCATC-3 0 (reverse). All quantitations were normalized to endogenous controls cyclophilin or hypoxanthine phosphoribosyl transferase . The relative quantitation value for each target gene compared to the calibrator for that target is expressed as 2
(C t and C c are the mean threshold cycle differences after normalizing to Cyclophilin or HPRT).
Analysis of Snail expression in mouse embryos CD-1 pregnant mice (Harlan) were killed by cervical dislocation; the embryos were removed by cesarean section, fixed in formalin and embedded in paraffin. Sections (4 mm) were dewaxed and rehydrated. Antigen retrieval was accomplished by boiling the samples in Tris-EDTA pH 9 for 15 min. Endogenous peroxidase activity was quenched with 4% hydrogen peroxide in PBS containing 0.1% sodium azide for 15 min. After several rinses with PBS, sections were incubated with PBS containing 1% BSA to block nonspecific binding and washed with PBS. Sections were incubated with 10 mg/ml of purified anti-Snail MAb EC3 overnight at 41C. After several further rinses with PBS, bound MAb was detected using antimouse Envision (Envision System Peroxidase, DAKO, Glostrup, Denmark). Sections were counterstained with hematoxylin.
Wound-healing assay in mice CD-1 mice were anesthetized with isoflurane (FORANE s , Abbot Laboratories, Abbot Park, IL, USA). After shaving the dorsal hair and cleaning the exposed skin with 70% ethanol, full-thickness excisional skin wounds of 2 mm diameter were made aseptically on either side of the dorsal midline using a 2 mm biopsy punch. Usually four wounds were made on the same animal. The wound tissue and surrounding skin from the wound margin were harvested from mice at 2, 3, 5 and 7 days post-wounding and fixed in formalin before paraffin embedding and sectioning at 4 mm. Paraffin sections were stained with hematoxylin and eosin and analysed with MAb EC3 (subclone EC11) as mentioned. This study and the analysis of murine embryos were approved by the Animal Experimentation Ethical Committee of IMAS (Barcelona, Spain).
Analysis of Snail expression in human samples
Retrospective paraffin-embedded biopsies form cervical squamous carcinomas, colon adenocarcinomas, fibrosarcomas, sarcomas and infantile fibromatosis were selected from the banks of the Servei d'Anatomia Patolo`gica, Hospital del Mar (Barcelona, Spain), or Departament de Patologı´a, Hospital Virgen de la Salud (Toledo, Spain). Paraffin sections (4 mm) were processed as indicated above for murine embryonic samples. Immunohistochemical staining was performed with MAb EC3 using the CSA II System (Dako Cytomation, DAKO) following the manufacturer's instructions. Consecutive sections were analysed with anti-E-cadherin MAb (BD Transduction). In this case, antigen retrieval was accomplished by boiling the samples in citrate buffer 10 mM pH 6 for 5 min. After blocking nonspecific binding by incubation with PBS supplemented with 1% skim milk, sections were treated with anti-E-cadherin MAb (1/2000 dilution) for 2 h at room temperature. Bound antibody was detected using anti-mouse Envision (Envision System Peroxidase, DAKO). Sections were counterstained with hematoxylin.
